LAUREN KIBBY: Open Payments
NPI 1023550423 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,582 in 94 payments from 20 companies in 2025. Trend: 2023 $1,557 · 2024 $1,846 · 2025 $1,582
Food & beverage: $1,582
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $270 |
| Novo Nordisk Inc | 20 | $204 |
| Lilly USA, LLC | 15 | $183 |
| AstraZeneca Pharmaceuticals LP | 9 | $159 |
| Axsome Therapeutics, Inc. | 7 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $118 |
| PFIZER INC. | 5 | $101 |
| Ardelyx, Inc. | 4 | $72 |
| Exact Sciences Corporation | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $53 |
Products named: MOUNJARO, QULIPTA, Symbravo, AIRSUPRA, Kerendia, NURTEC ODT, Ozempic, IBSRELA.
Industry payments across GA — which companies pay providers there.
